Department of Epidemiology, Emory University, 1518 Clifton Rd., Atlanta, GA, 30322, USA.
Division of HIV/AIDS Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
AIDS Behav. 2020 Jun;24(6):1865-1875. doi: 10.1007/s10461-019-02761-9.
Amphetamine use is higher among men who have sex with men (MSM) compared with other men, and is associated with sexual behavior linked to HIV transmission. No national estimates of amphetamine use among MSM with HIV have been published. We used data from the Medical Monitoring Project, a nationally representative sample of persons with diagnosed HIV, to describe patterns in amphetamine use in the past 12 months among MSM during 2015-2016 (N = 3796). Prevalence of amphetamine use in this population was 9.6% (95% CI 7.6, 11.6%) in the past 12 months. MSM who used amphetamines were more likely to have condomless sex with partners without HIV or of unknown serostatus (PR 1.87; 95% CI 1.62, 2.16) and less likely to be durably virally suppressed (PR 0.81; 95% CI 0.71, 0.91). Interventions to address amphetamine use and associated transmission risk behaviors among MSM living with HIV may decrease transmission.
安非他命的使用在男男性行为者（MSM）中高于其他男性，并且与与 HIV 传播相关的性行为有关。目前尚未发表针对 HIV 感染的 MSM 中安非他命使用的全国估计数。我们使用了医疗监测项目的数据，该项目是诊断出 HIV 的人员的全国代表性样本，以描述 2015-2016 年期间（N = 3796）MSM 在过去 12 个月中安非他命使用的模式。在该人群中，过去 12 个月中安非他命的使用流行率为 9.6%（95%CI 7.6，11.6%）。使用安非他命的 MSM 与 HIV 阴性或血清状况未知的伴侣发生无保护性行为的可能性更高（PR 1.87；95%CI 1.62，2.16），而持续病毒抑制的可能性更低（PR 0.81；95%CI 0.71，0.91）。针对 HIV 感染者中 MSM 使用安非他命和相关传播风险行为的干预措施可能会降低传播风险。
